Open AccessThe value of contrast-enhanced ultrasonography to detect the sacroiliac joint for predicting relapse after discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis
Author(s) -
Jiayu Ren,
Jianhong Zhu,
Diancheng Li,
Wenxue Li,
Fang Liu
Publication year - 2019
Publication title -
quantitative imaging in medicine and surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 21
eISSN - 2223-4292
pISSN - 2223-4306
DOI - 10.21037/qims.2019.06.06
Subject(s) - medicine , ankylosing spondylitis , basdai , discontinuation , sacroiliac joint , spondylitis , radiology , tumor necrosis factor alpha , rheumatoid arthritis , psoriatic arthritis
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by high relapse. Therefore, the present study aimed to investigate the ultrasonographic features of contrast-enhanced ultrasonography (CEUS) in the sacroiliac joint (SIJ) in patients with AS in remission after discontinuation of anti-tumor necrosis factor (TNF) therapy, and also examined the role of CEUS in predicting relapse.